International Journal of Sexually Transmitted Diseases

About The Journal

The International Journal of Sexually Transmitted Diseases (IJSTD) is a leading open access publication that focuses on the prevention, diagnosis, and treatment of sexually transmitted diseases and infections (STDs). The journal provides timely and comprehensive coverage of the latest advances in the field, focusing on the issues of public health, medical research and technology, policy, and cultural perspectives.

Mission

The mission of the IJSTD is to promote the communication and exchange of knowledge, research, and ideas in the field of STDs. With an interdisciplinary approach, the journal provides an important forum for physicians, nurses, public health professionals, allied health professionals, scientists, and other healthcare professionals to discuss and debate issues affecting the health of individuals and communities worldwide. IJSTD offers a global platform for publishing research and ideas in STD prevention, diagnosis, and treatment, encouraging contributions from individuals and organizations in both the developed and developing world.

Scope

The International Journal of Sexually Transmitted Diseases (IJSTD) provides a platform for sharing research and insights on all aspects of sexually transmitted infections (STIs). The journal covers:

• Epidemiology and Public Health: Studies on the prevalence, distribution, and control of STIs.
• Clinical and Diagnostic Studies: Research on clinical manifestations and diagnostic advancements.
• Treatment and Prevention: Innovations in therapy, prophylaxis, and vaccination.
• Behavioral Studies: Examination of sexual behaviors and psychosocial factors.
• Microbiology and Immunology: Investigations into STI pathogens and immune interactions.
• Sociocultural Aspects: Exploration of cultural, social, and psychological factors.
• Policy and Health Systems: Analysis of health policies and economic aspects.
• Global Health and Disparities: Research on STI impacts and health disparities globally.

Submission and Review Process

Submission of an article to the (IJSTD) implies an original and unpublished work, not under consideration elsewhere. Authors should follow the Instructions for Authors carefully prior to submitting their manuscript. The Instructions for Authors provide detailed guidance on the preparation and structure of an article and the standards that submissions should meet. Once an article has been accepted, IJSTD will be prepared for publication in an appropriate format and published in a timely manner.

Submissions can be made in two ways:

• Online: Authors can submit their articles online through user-friendly submission system, which only takes a few minutes to complete. 
• Offline: Submit manuscript via email to editorial office.

Article Processing Charges

Authors are required to pay Article Processing Charges (APCs) for all published work in IJSTD to make their work freely available upon acceptance. These APCs are necessary to maintain the quality of published research, as well as to provide open access to the widest possible audience. Authors are required to pay the publication fee or APC only upon acceptance of their manuscript. 

Types of Publications

• Editorials: Expert opinions on current issues.
• Original Research Articles: Detailed studies reporting new findings.
• Review Articles: Comprehensive overviews of specific topics.
• Case Reports: Detailed presentations of individual cases.
• Short Communications: Brief reports of significant research.
• Letters to the Editor: Responses to previously published articles.
• Special Issues: Collections of articles on specific themes.
• Clinical Case Images: Visual documentation of clinical cases.
• Conference Proceedings: Summaries of conference presentations.
• Methodology Articles: Descriptions of new research methods.
• Hypotheses: Proposals for new research directions.
• Systematic Reviews: Analyses of existing research.
• Data Reports: Presentations of new datasets.

Open Access Policy

IJSTD operates under an open access model, ensuring that all published articles are freely available to researchers and the public worldwide. This promotes greater dissemination and accessibility of scientific knowledge, contributing to the advancement of research and public health practices in the field of sexually transmitted diseases.

Editorial Board

The editorial board of the (IJSTD) comprises esteemed experts and leaders in the field of sexually transmitted diseases from around the world. They bring diverse expertise and insights, ensuring the publication of impactful and innovative research.

Advantages of Publishing with IJSTD

IJSTD provides authors the opportunity to submit their original research findings to a wide international readership and to make those findings freely available to all. IJSTD promotes interdisciplinary discussions and reviews in the field of sexually transmitted infections, encouraging collaboration among researchers from different disciplines to stimulate novel approaches and discoveries.

Testimonial

• ORAIN Edward Paul, Ryazan State University, Russia: Thanks for all your help with the manuscript. I think this is a good option for a wide publication. I`d like to recommend this scientific journal to all scientific workers. This recommendation is especially useful for novice researchers in the era of a global pandemic and the more complex communications of our time. The editors of the journal are very patient and correct in dealing with the authors of the manuscripts. For this I would like to thank all the colleagues involved in the publishing process
• Jianqing Wu, United States: OPEN ACCESS PUB's publication model is better than other open assess publishers' in several aspects. It is honest, does what it has agreed, always honors authors' intention and work quality is predictable. Its staff delivers its works in a timely manner and yet can give authors required time if authors need. It has required ingredients for being a successful science publisher.

Contact Us

For any queries or further information, please contact us via email.